Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200055367Phase 4Recruiting
Phase 4, randomised, double-blind trial in asthma comparing Experimental group: Suhuang Zhike Capsules with Control group: Suhuang Zhike Capsule placebo (2 arms). Primary endpoint: ACT score. Started Jan 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200055367.